News for Globus Medical, Inc. (GMED.MX)

Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (

In recent updates, Morgan Stanley, led by analyst Drew Ranieri, has made adjustments to their price target for Globus Medical (GMED). Despite maintaining an "Ov

Shares of Globus Medical Inc (GMED) fell 4.14% in mid-day trading on Jul 7. The stock reached an intraday low of $56.59, before recovering slightly to $56.72,

In the current session, Globus Medical Inc. GMED is trading at $58.35, after a 0.53% decrease. Over the past month, the stock fell by 1.45%, and in the past yea...

PR NewswireNEW YORK, June 22, 2025 NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical,

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (”œGlobus” or the ”œComp

PR NewswireNEW YORK, June 17, 2025 NEW YORK, June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical,

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (”œGlobus” or the ”œComp

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (”œGlobus” or the ”œComp

Barclays maintains its positive outlook on Globus Medical (GMED) shares, despite an unexpected first-quarter shortfall. Analyst Matt Miksic highlights the firm'

PR NewswireNEW YORK, June 7, 2025 NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, In

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (”œGlobus” or the ”œComp

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (”œGlobus” or the ”œCompa

PR NewswireNEW YORK, June 1, 2025 NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, In

In the current session, Globus Medical Inc. GMED is trading at $59.40, after a 0.32% drop. Over the past month, the stock fell by 17.24%, and in the past year, ...

Zimmer Biomet Holdings, Inc. (ZBH) has announced the appointment of Kevin Thornal to the newly-created position of Group President, Global Businesses and the

Globus Medical (GMED) has recently seen its rating reaffirmed by JMP Securities. The latest report from analyst David Turkaly, released on May 27, 2025, maintai

In a recent development, Globus Medical (GMED) has received a downgrade in its stock rating from BTIG. The analyst behind this adjustment is Ryan Zimmerman, who

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...